Acorah Software Products - Accounts Production 15.0.500 false true false true No description of principal activity 6 June 2023 30 June 2024 30 June 2024 14918474 Dr Elena Xenophontos iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14918474 2023-06-05 14918474 2024-06-30 14918474 2023-06-06 2024-06-30 14918474 frs-core:CurrentFinancialInstruments 2024-06-30 14918474 frs-bus:PrivateLimitedCompanyLtd 2023-06-06 2024-06-30 14918474 frs-bus:FilletedAccounts 2023-06-06 2024-06-30 14918474 frs-bus:Micro-entities 2023-06-06 2024-06-30 14918474 frs-bus:AuditExempt-NoAccountantsReport 2023-06-06 2024-06-30 14918474 frs-bus:Director1 2023-06-06 2024-06-30
Registered number: 14918474
Therapy Matrix Limited
Unaudited Financial Statements
For the Period 6 June 2023 to 30 June 2024
More Than Accountants Ltd
Balance Sheet
Registered number: 14918474
30 June 2024
£
Fixed assets 412
Current assets 3,733
Creditors: Amounts Falling Due Within One Year (2,527 )
NET CURRENT ASSETS 1,206
TOTAL ASSETS LESS CURRENT LIABILITIES 1,618
NET ASSETS 1,618
CAPITAL AND RESERVES 1,618

Notes

1. General Information
Therapy Matrix Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14918474 . The registered office is Ground Floor, Nautica House, Waters Meeting Road, Bolton, BL1 8SW.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Elena Xenophontos
Director
31/07/2024